Cargando…

Inhibition of dipeptidyl peptidase-4 ameliorates cardiac ischemia and systolic dysfunction by up-regulating the FGF-2/EGR-1 pathway

Dipeptidyl peptidase 4 inhibitors are used worldwide in the management of diabetes, but their role in the prevention or treatment of cardiovascular disorders has yet to be defined. We found that linagliptin, a DPP-4 inhibitor, suppressed capillary rarefaction in the hearts of mice with dietary obesi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suda, Masayoshi, Shimizu, Ippei, Yoshida, Yohko, Hayashi, Yuka, Ikegami, Ryutaro, Katsuumi, Goro, Wakasugi, Takayuki, Yoshida, Yutaka, Okuda, Shujiro, Soga, Tomoyoshi, Minamino, Tohru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542565/ https://www.ncbi.nlm.nih.gov/pubmed/28771625 http://dx.doi.org/10.1371/journal.pone.0182422

Ejemplares similares

Empagliflozin maintains capillarization and improves cardiac function in a murine model of left ventricular pressure overload
por: Nakao, Masaaki, et al.
Publicado: (2021)

Differing impact of phosphoglycerate mutase 1-deficiency on brown and white adipose tissue
por: Yoshida, Yohko, et al.
Publicado: (2022)

Boysenberry polyphenol inhibits endothelial dysfunction and improves vascular health
por: Furuuchi, Ryo, et al.
Publicado: (2018)

Role of smooth muscle cell p53 in pulmonary arterial hypertension
por: Wakasugi, Takayuki, et al.
Publicado: (2019)

Peptide vaccine for semaphorin3E ameliorates systemic glucose intolerance in mice with dietary obesity
por: Yoshida, Yohko, et al.
Publicado: (2019)

Cardiac mitofusin-1 is reduced in non-responding patients with idiopathic dilated cardiomyopathy
por: Hsiao, Yung Ting, et al.
Publicado: (2021)

The pathological role of vascular aging in cardio-metabolic disorder
por: Katsuumi, Goro, et al.
Publicado: (2016)

Vascular Senescence in Cardiovascular and Metabolic Diseases
por: Katsuumi, Goro, et al.
Publicado: (2018)

Endothelial SIRT-1 has a critical role in the maintenance of capillarization in brown adipose tissue
por: Furuuchi, Ryo, et al.
Publicado: (2022)

Coagulation factors promote brown adipose tissue dysfunction and abnormal systemic metabolism in obesity
por: Hayashi, Yuka, et al.
Publicado: (2022)

Glycoprotein nonmetastatic melanoma protein B regulates lysosomal integrity and lifespan of senescent cells
por: Suda, Masayoshi, et al.
Publicado: (2022)

Brown adipose tissue dysfunction promotes heart failure via a trimethylamine N-oxide-dependent mechanism
por: Yoshida, Yohko, et al.
Publicado: (2022)

Capillaries as a Therapeutic Target for Heart Failure
por: Yoshida, Yohko, et al.
Publicado: (2022)

New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
por: Cui, Chenkai, et al.
Publicado: (2022)

Role of circulating molecules in age-related cardiovascular and metabolic disorders
por: Hsiao, Yung Ting, et al.
Publicado: (2022)

Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors
por: Shibasaki, Ikuko, et al.
Publicado: (2022)

Evolutionary Analysis of Dipeptidyl Peptidase I
por: Varda, Nina, et al.
Publicado: (2022)

Notch Signaling Regulates the Lifespan of Vascular Endothelial Cells via a p16-Dependent Pathway
por: Yoshida, Yohko, et al.
Publicado: (2014)

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
por: Kim, Na-Hyung, et al.
Publicado: (2014)

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes
por: Shi, Sen, et al.
Publicado: (2016)

Tackling dipeptidyl peptidase IV in neurological disorders
por: Al-Badri, Ghaith, et al.
Publicado: (2018)

Dipeptidyl Peptidase IV as a Muscle Myokine
por: Kluess, Heidi A.
Publicado: (2020)

Angioedema associated with dipeptidyl peptidase-IV inhibitors
por: Cassano, Nicoletta, et al.
Publicado: (2021)

Peptidases in human bronchoalveolar lining fluid, macrophages, and epithelial cells: Dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme)()
por: Juillerat-Jeanneret, Lucienne, et al.
Publicado: (1997)

The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
por: Kanasaki, Keizo
Publicado: (2018)

Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction
por: Li, Jing Wei, et al.
Publicado: (2017)

Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitor showing unfavorable outcomes despite immediate discontinuation of medication
por: Shinohara, Yasutake, et al.
Publicado: (2020)

Correction: The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
por: Kanasaki, Keizo
Publicado: (2019)

Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors
por: Hong, Sangmo, et al.
Publicado: (2022)

Non-Specific Inhibition of Dipeptidyl Peptidases 8/9 by Dipeptidyl Peptidase 4 Inhibitors Negatively Affects Mesenchymal Stem Cell Differentiation
por: Torrecillas-Baena, Bárbara, et al.
Publicado: (2023)

Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
por: Esaki, Hiroki, et al.
Publicado: (2017)

Health economic evaluation of dipeptidyl peptidase-4 inhibitors
por: Garg, Vishvas
Publicado: (2011)

Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose
por: Das, Siddhartha Shankar, et al.
Publicado: (2014)

Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions
por: Singh, Awadhesh Kumar
Publicado: (2014)

Navigating the chemical space of dipeptidyl peptidase-4 inhibitors
por: Shoombuatong, Watshara, et al.
Publicado: (2015)

Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Outcome
por: Kim, Kwang-il
Publicado: (2018)

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
por: Tasanen, Kaisa, et al.
Publicado: (2019)

Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism
por: Trzaskalski, Natasha A, et al.
Publicado: (2020)

Dipeptidyl peptidase-4 (DPP-4; CD26)
Publicado: (2013)

Dipeptidyl peptidase 4 inhibitors: Applications in innate immunity?
por: Yazbeck, R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jf8af0j9ptn9a2k52n27jrko3i